Improved retroviral transduction of hematopoietic progenitors by combining methods to enhance virus-cell interaction

Leukemia

Volumn 14, Issue 2, 2000, Pages 307-311

  Liu, H ^a   Hung, Y ^a   Wissink, S D ^a   Verfaillie, C M ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Box 806 ^*  (United States)

Author keywords

Cationic lipids; CH296; Hematopoietic progenitor; Retroviral transduction; Transwell flow through system

Indexed keywords

ANTIBIOTIC G 418; FIBRONECTIN; LIPID;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETROVIRUS; TECHNIQUE; VIRUS CELL INTERACTION;

EID: 0033975926     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401672     Document Type: Article

References (24)

1. Havenga M, Hoogerbrugge P, Valerio D, van Es HH. Retroviral stem cell gene therapy. Stem Cells 1997; 15: 162-179.
2. Chu P, Lutzko C, Steward A, Dube ID. Rotrovirus-mediated gene transfer into human hematopoietic stem cells. J Molec Med 1998; 76: 184-192.
3. Richardson C, Bank A. Developmental-stage-specific expression and regulation of an amphotropic retroviral receptor in hematopoietic cells. Molec Cell Biol 1996; 16: 4240-4247.
4. Andreadis ST, Palsson BO. Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5-7.5 hours. J Virol 1997; 71: 7541-7548.
5. Palsson B, Andreadis S. The physico-chemical factors that govern retrovirus-mediated gene transfer. Exp Hematol 1997; 25: 94-102.
6. Chuck AS, Clarke MF, Palsson BO. Retroviral infection is limited by Brownian motion. Hum Gene Ther 1996; 7: 1527-1534.
7. Bagnis C, Chischportich C, Imbert AM, Van den Broeke A, Cornet V, Mannoni P. Efficiency of retroviral transduction into hematopoietic cells by cocultivation procedure does not correlate with viral titer. Cancer Gene Ther 1997; 4: 5-8.
8. Forestell SP, Boehnlein E, Rigg RJ. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production. Gene Therapy 1995; 2: 723-730.
9. Sekhar M, Kotani H, Doren S, Agarwal R, McGarrity G, Dunbar CE. Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions. Hum Gene Ther 1996; 7: 33-38.
10. Conneally E, Eaves CJ, Humphries RK. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood 1998; 91: 3487-3493.
11. Hodgson CP, Solaiman F. Virosomes: cationic liposomes enhances retroviral transduction. Nature Biotechnol 1996; 14: 339-342.
12. Kaneko Y, Tsukamoto A. Cationic liposomes enhance retrovirsusmediated multinucleated cell formation and retroviral transduction. Cancer Lett 1996; 105: 39-44.
13. Kaneko Y, Tsukamoto A. Structural characteristics of cationic liposomes with potent enhancing effect on retroviral transduction into human hepatoma cells. Cancer Lett 1996; 107: 211-215.
14. Punzel M, Wissink SD. Miller JS, Moore KA, Lemischka IR, Verfaillie CM. The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro. Blood 1999; 93: 3750-3756.
15. Cone RD, Mulligan RC. High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. Proc Natl Acad Sci USA 1984; 81: 6349-6353.
16. Lundell BI, McCarthy JB, Kovach NL, Verfaillie CM. Activation-dependent alpha5betal integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells. Blood 1996; 87: 2450-2458.
17. Zhao RC, McIvor RS, Griffin JD, Verfaillie CM. Gene therapy for chronic myelogenous leukemia (CML): a retroviral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo. Blood 1997; 90: 4687-4698.
18. Porter CD, Lukacs KV, Box G, Takeuchi Y, Collins MKL. Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo. J Virol 1998; 72: 4832-4840.
19. Fasbender A, Zabner J, Chillon M, Moninger TO, Puga AP, Davison BI., Welsh MJ. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem 1997; 272: 6479-6489.
20. Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Adachi A, Williams DA. Colocalization of retroviruses and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nature Med 1996; 2: 876-882.
21. Moritz T, Dutt P, Xiao X, Carstanjen D, Vik T, Hanenberg H, Williams DA. Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxyl-terminal fragments. Blood 1996; 88: 855-862.
22. Ohneda O, Fennie C, Zheng Z, Donahue C, La H, Villacorta R, Cairns B, Lasky LA. Hematopoietic stem cell maintenance and differentiation are supported by embryonic aorta-gonad mesonephros region-derived endothelium. Blood 1998; 92: 908-919.
23. Verfaillie CM. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 1993; 82: 2045-2053.
24. Brandt JE, Galy AH, Luens KM, Travis M, Young J, Tong J, Chen S, Davis TA, Lee KP, Chen BP, Tushinski R, Hoffmann R. Bone marrow repopulation by human marrow stem cells after long-term expansion culture on a porcine endothelial cell line. Exp Hematol 1998; 26: 951-961.